PROFILE
Laman Web Staf UPM
DR. MUHAMMAD HISHAR BIN HASSAN
PEGAWAI PENYELIDIK
PUSAT PENGIMEJAN DIAGNOSTIK NUKLEAR
muhdhishar@upm.edu.my
PROFESIONAL
NAMA :
(Dr.) MUHAMMAD HISHAR BIN HASSAN
JAWATAN :
PEGAWAI PENYELIDIK
PTJ :
PUSAT PENGIMEJAN DIAGNOSTIK NUKLEAR
DOWNLOAD CURRICULUM VITAE (PDF)
LATARBELAKANG PENDIDIKAN
2023
Doktor Falsafah (Pengimejan Molekul), UPM
2019
IAEA Fellowship (Sains Radiofarmaseutikal), Westmead Hosp, NSW, Australia
2016
Master of Sains (Pengimejan Molekul), UPM
2009
Professional Certificate (Pegawai Perlindungan Sinaran - Fasiliti Siklotron), AELB
2008
Professional Certificate (Pengendalian Radioisotop), UWA, Australia
2008
Preceptorship (Pengurusan Siklotron Perubatan & Penghasilan Radiofarmaseutikal PET), SCGH, WA, Australia
2007
Bachelor of Science (Biotechnology), Monash University
PERKHIDMATAN PERUNDINGAN
2018
Editorial Board Member of Annals of Medicine & Medical Research
2017
Koordinator Projek Kerjasama IAEA
2015
Editorial Board Member of SM Radiology Journal
2014
Konsultan, BV Logistics Sdn. Bhd.
2012
Pegawai Perlindungan Sinaran, BV Logistics Sdn. Bhd.
PERSIDANGAN / BENGKEL / SEMINAR
2024
Aluminum Fluorination: Expanding the Role of Fluorine-18 in Biomolecule Labeling Strategies. Malaysia Nuclear Medicine Annual Conference 2024, Kuala Lumpur
2021
NOTA-Pamidronate kit: Novel Fluoride-18 (F-18)-based bone scanning agent. Pharm-IIDEx 2021, UiTM, Malaysia
2013
Investigation on the influence of waiting time period on the PET image quality. College of Radiology Annual Scientific Meeting 2013
PEMBENTANGAN KERTAS KERJA
2025
Radiolabeled pamidronate: A promising theranostic approach in personalized bone cancer management. International Conference on Advances in Radiation Oncology (ICARO-4), IAEA, Austria.
2025
18F-Florapronol (FC119S) in amyloid-β PET imaging: A comprehensive review of radiochemical innovation, clinical validation and diagnostic impact in Alzheimer’s disease. Annual Congress of Malaysian Nuclear Medicine (MyNM 2025), Kuala Lumpur, Malaysia.
2024
A novel NOTAPAM radiolabeling with 68Ga. British Nuclear Medicine Society Annual Spring Meeting, Belfast, Ireland.
2024
Navigating radiolabeling challenges: Our experience with NOTA-pamidronic acid and [18F]AlF2+ complexes alongside 68Ga3+ ions. IPET 2024, Vienna, Austria
2023
Optimal radiolabeling conditions for [18F]AlF-NOTA-moiety. ISTR 2023, Vienna, Austria.
2023
[18F]AlF-complexation of pamidronic acid, a NOTA-conjugated bisphosphonate, as a potential tracer for PET bone imaging. European Association of Nuclear Medicine Congress 2023, Vienna, Austria.
2015
Optimizing the azeotropic drying of 18F- way to improve 18F-Fluorocholine radiochemical yields! European Association of Nuclear Medicine Congress 2015, Hamburg, Germany.
2015
Simplified and reliable quality control analysis method of 18F-Fluorocholine for a small scale hot lab. European Association of Nuclear Medicine Congress 2015, Hamburg, Germany.
2014
Patient dose management: Should we move to lean body mass? United Kingdom Radiological Congress 2014, Manchester, United Kingdom.
2013
Investigation on the influence of dose minimization management on the PET image quality. United Kingdom Radiological Congress 2013, Liverpool, United Kingdom.
2012
Association of total activity 18F-FDG injected with the overall PET image quality in oncology patients. National Conference on Physics 2012.
PENGAJARAN
PET Radiopharmaceuticals in PET/CT Course organized by PPDN (2012 - sekarang)
JAWATANKUASA
2023
AJK Teknikal Dasar Teknologi Nuklear Negara (DTNN) 2030
2022
World Council on Isotopes (WCI)
2021
Affiliate Member, Royal Society of Chemistry (RSC)
2015
Ahli European Association of Nuclear Medicine
ANUGERAH DAN PENCAPAIAN
2025
Geran Perjalanan to ICARO-4, Vienna, Austria, 2 - 5 June 2025 (tajaan penuh IAEA, EUR 1,900)
2024
Geran Perjalanan to IPET 2024, Vienna, Austria, 7 - 11 October 2024 (tajaan penuh IAEA, EUR 2120)
2021
Pingat Gangsa, Pharm-IIDEx, Inspiring Innovation and Discovery
2019
Hadiah Latihan Persekutuan (HLP SLPP), KPM (2019 - 2022)
2019
Program Fellowship (tajaan penuh IAEA, EUR 4,060) ke Westmead Hospital, Sydney, Australia, 4 Feb - 1 Mac 2019
2018
Anugerah Perkhidmatan Cemerlang 2017
2016
Lawatan Saintifik (tajaan penuh IAEA, USD 3,138) ke All India Institute of Medical Sciences, New Delhi, India, 1 - 12 Februari 2016
2014
Lawatan Santifik (tajaan penuh IAEA, USD 6,780) ke San Raffaele Hospital, Milan & University of Milano-Bicocca, Milan, Italy, 15 - 26 September 2014
2013
Anugerah "Top 10" Poster Saintifik di UKRC, Liverpool, UK
2003
Biasiswa MARA (Asasi & Siswazah)
BIDANG PENGKHUSUSAN
Cyclotron & sains radiofarmaseutikal
PROJEK PENYELIDIKAN
2023
Geran Universiti Putra Malaysia (IPM), RM40,000
2021
Geran Kolaborasi UiTM, RM20,000 - Penyelidik Bersama
2017
Geran Universiti Putra Malaysia (Geran Putra), RM40,000 - Penyelidik Utama
2014
Fundamental Research Grant Scheme (FRGS), RM110,000 - Penyelidik Bersama
2013
Geran Universiti Putra Malaysia (IPM), RM42,000 - Penyelidik Utama
2012
Research University Grant Scheme (RUGS), RM30,000 - Penyelidik Utama
2012
Research University Grant Scheme (RUGS), RM30,000 - Penyelidik Bersama
PENERBITAN
2025
In vivo biodistribution analysis of [68Ga]Ga-NOTA-pamidronic acid and [68Ga]Ga-DOTA-pamidronic acid: Insights into bone-targeting radiopharmaceuticals
2023
The potential of radiolabeled bisphosphonates in SPECT and PET for bone imaging
2022
Preparation, optimisation and in vitro evaluation of [18F]AlF-NOTA-Pamidronic acid for bone imaging PET
2019
18F[AlF]-radiolabeled Peptides on the Automated Synthesis Platform: Translating the Laboratory Bench Work to Bedside
2016
Synthesis of Fluorine-18-labelled Choline (18F-Fluorocholine): towards an early and accurate management of prostate cancer in Malaysia
2016
Optimising the Azeotropic Drying of 18F-Fluorine Way to Improve the 18F-Fluorocholine Radiochemical Yield
2016
Convenient and efficient method for quality control analysis of 18F-Fluorocholine: for a small scale GMP-based radiopharmaceuticals set-up
2016
Potentials of 3’-fluoro-3’ deoxythymidine as a cellular proliferation marker in PET oncology examination
2015
Improving the 18F-Fluoromethylcholine (18F-FCH) radiochemical yield via optimising the azeotropic drying of non-carrier-added 18F-Fluorine
2015
Prostate cancer imaging: A new era in diagnostic approach
2015
Dose Optimisation of 18F-Flurodeoxyglucose for Whole Body PET Oncology Examination in CDNI of UPM
2014
Investigation on the influence of dose minimisation management on the PET image quality
2014
The role of PET camera emission as an alternative method for radioactivity spillage measurement during PET/CT study